Objectives: Autoantibodies mimicking alloantibodies (referred to as mimicking antibodies) are a type of specific antibody that reacts with all red blood cells, but exhibits a stronger reaction with red blood cells expressing the target antigens. This study aimed to explore immunohematologic methods for identifying mimicking antibodies, autoantibodies and alloantibodies, and to formulate safe transfusion strategies based on the results.

Methods: ABO, Rh blood types and direct antiglobulin test were determined using the tube saline method. Antibody detection and identification were performed using tube saline and anti-human globulin microcolumn gel method with two sets of panel red blood cells. The specificity of antibodies was confirmed through absorption elution test, antibody dilution and titer integral method.

Results: The study identified the presence of both anti-c and anti-E alloantibodies as well as anti-c and anti-E mimicking antibodies in patient samples. Based on these findings, suitable A-type CCDee donors can be selected for the patient, while avoiding both mimicking antibodies and alloantibodies.

Conclusion: When mimicking antibodies, autoantibodies and alloantibodies are present in patients, either separately or simultaneously, antibody identification can be challenging. Accurate determination of the type and specificity of antibodies is essential for developing safe transfusion strategies in clinical practice.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11748685PMC
http://dx.doi.org/10.1016/j.heliyon.2024.e41079DOI Listing

Publication Analysis

Top Keywords

mimicking antibodies
20
red blood
12
blood cells
12
anti-c alloantibodies
8
autoantibodies mimicking
8
antibodies autoantibodies
8
autoantibodies alloantibodies
8
safe transfusion
8
transfusion strategies
8
tube saline
8

Similar Publications

Objectives: Autoantibodies mimicking alloantibodies (referred to as mimicking antibodies) are a type of specific antibody that reacts with all red blood cells, but exhibits a stronger reaction with red blood cells expressing the target antigens. This study aimed to explore immunohematologic methods for identifying mimicking antibodies, autoantibodies and alloantibodies, and to formulate safe transfusion strategies based on the results.

Methods: ABO, Rh blood types and direct antiglobulin test were determined using the tube saline method.

View Article and Find Full Text PDF

Separation of a monoclonal antibody (mAb) from impurities was examined on different cation exchange resins (CEX), including POROS XS, POROS HS, NUVIA S, and NUVIA HRS. Impurities mainly consisted of cell culture-derived mAb fragments, or lysozyme, that mimicked the presence of an adsorbing protein of low molecular weight. The choice between the flowthrough mode and the bind-and-elute mode for the purification was guided by the shape of the adsorption isotherm.

View Article and Find Full Text PDF

Calcitonin gene-related peptide (CGRP) biases Langerhans cell (LC) Ag presentation to CD4 T cells towards Th17-type immunity through actions on endothelial cells (ECs). We now report further evidence that IL-6 signalling at responding T cells mediates this effect. This CGRP effect was absent with ECs from IL-6 KO mice.

View Article and Find Full Text PDF

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and neuromyelitis optica spectrum disorders (NMOSD) are two rare autoimmune inflammatory demyelinating diseases involving the central nervous system, which are often seen with combined involvement of the optic nerve and spinal cord. MOGAD can be confused with multiple sclerosis or NMOSD, due to its clinical presentation that may be similar and its characteristic to progress with habitual attacks. Although the clinical course of the above-mentioned three diseases is similar, their diagnosis and management are different.

View Article and Find Full Text PDF

Background And Objectives: Dyslipidemia has been reported to contribute to the psoriasis pathogenesis. Thus, evinacumab, a novel lipid-lowering drug targeting angiopoietin-like 3, may have therapeutic potential to treat and/or manage psoriasis.

Methods And Study Design: Summary statistics were obtained from genome-wide association studies addressing psoriasis (FinnGen Consortium; n=216,752) and serum lipid concentrations (United Kingdom Biobank; n=403,943-440,546).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!